INTRODUCTION
Depressive disorders fulfilling the DSM-III-R (1), DSM-IV (2), or ICD-10 diagnostic criteria (3) for major depressive disorder (MDD) and dysthymic disorder (DD) are psychological conditions with a relatively high prevalence. The point prevalence for MDD in the industrialized word ranged from 2 to 4% (4-6) in the community, 5-10% in primary care, and 10-14% in medical inpatients care (4) . Prevalence increases 2-3 times in each setting when only some of the MDD criteria are fulfilled (4, 6) .
Patients with depressive disorders have substantial limitations in physical (7) , interpersonal (8) , social (8) , and occupational functioning (9) . The extent of functional limitations is often equal to or even greater than those of chronic general medical conditions (8) (9) (10) . The concept of functioning have been included for diagnosing depressive disorders both in WHO's ICD-10 (3) and in APA's DSM-IV (2) . In 2020, depressive disorders will be the second leading cause for disability-adjusted life years (11) .
Despite convincing evidence of the relationship between depressive psychopathology and functional limitations (9, 10) , concepts of individual function were used less frequently than concepts of body function in the outcome assessment of depressive disorders. Depression scales are among the oldest and best established health status measures, many of them are more than 20 years old (12) (13) (14) , a few are about 40 years or even older (15) (16) (17) , and are mainly symptom-based (18) . Only a few functional concepts such as "indecisiveness" (14, 16, 17) , "social withdrawal" (13, 14, 16) , or "work difficulties" (13, 15, 16, 19) are considered in some scales.
Based on the new International Classification of Functioning, Disability and Health (ICF) (20) which was endorsed by the Word Health Assembly in May 2001 as a reference or common language of functioning and health, it is now possible to identify, quantify and compare the concepts contained in different outcome measures (21) .
The objective of this systematic review therefore was to identify and quantify the concepts contained in the outcome measures of randomized controlled trials (RCTs) for interventions in depressive disorders using the ICF as a reference tool. The specific aims were: (i) to determine the frequency of ICF categories linked to the concepts contained within the outcome measures; (ii) explore differences in the use of ICF categories across different intervention types; and (iii) examine which and how often health status measures have been applied in trials on depressive disorders.
METHODS

Study design
A systematic review was performed in 3 steps: step 1, selection of studies, step 2, outcome measures extraction and, step 3, linkage of the concepts contained within the outcomes measures to the corresponding categories of the ICF. All steps were carried out by 2 independent reviewers.
In step 1, selection of studies, RCTs between the years 1991 and 2000 were located in MEDLINE 1 , Silver Platter, 2000 Edition, using Dickersin's et al. (22) highly precise search strategy (sets 1-8). Thereafter, the Dickersin search was combined with a condition-specific search strategy using the "and" operator.
To locate trials on depressive disorders, the explode-functions for "Depressive-Disorders", "Depression", "Dysthymic Disorder", and "Seasonal-Affective Disorder" with all subheadings and the free text words "depress*" and "dysthymic" restricted to the abstract and title section were combined using the "or" operator.
All searches were limited to English articles. The abstracts were checked applying general and condition-specific eligibility criteria. For the selected trials the original study reports were ordered and reviewed applying again the same eligibility criteria. The finally included studies entered step II of the review. A study met general eligibility, if the study design was a RCT, the experimental intervention had a therapeutic aim, the study was on humans, the report was in English and, if none of the following exclusion criteria were fulfilled: randomized n of 1 study, reviews, secondary analyses, psychometric studies, primary prevention studies (healthy population at risk), and mode of action studies. In the case of multiple publications, the paper with the highest impact factor was included.
To identify the appropriate study population condition-specific eligibility criteria were applied. The diagnosis of MDD, DD, or double depression (DD with superimposed major depressive episodes) according to the DSM-III-R (1) or DSM-IV diagnostic criteria (2) or the diagnosis of depressive episode, recurrent depressive disorders, or dysthymia according to the ICD-10 (3) or related terms or classifications with a comparable meaning (e.g. endogenous depression for MDD, chronic minor depression for DD, etc.) has to be reported to describe the study population. Studies on populations with minor depression/minor depressive disorder according to the diagnostic criteria of DSM-III-R/ DSM-IV, bipolar disorders, cyclothymic disorders, mood disorder due to a general medical condition (e.g. post-stroke depression (23)) or a substance (e.g. withdrawal from cocaine) and risk patients (e.g. history of depressive illness in first-degree relatives) were excluded.
In step 2, outcome measures extraction, all types of outcome measures and some study characteristics on study population and intervention were extracted.
Outcome measures included clinician-rated and self-rated questionnaires, single item measures on different domains such as nausea, dry mouth, insomnia, dizziness, etc., biochemical test (e.g. liver or kidney function, drug blood level, etc.), and test batteries on memory or intelligence. If the items of a questionnaire were not specified in the publication, we obtained the questionnaire by reference checking, searches in databases or books on health status measures (18, 24) , e-mail consultation with the developers of the questionnaire in demand, or internet searches, and then the items were extracted.
Study characteristics included parameters such as subtype of condition (MDD, DD, double depression, or combination of these categories), age, the country of performance of the trial, and the type of experimental intervention ("drug therapy", "physical or rehabilitative therapy", or "different therapeutic modalities"). "Different therapeutic modalities" was chosen in studies with more than 1 experimental group and different intervention types such as comparisons of psychotherapy vs pharmacotherapy with an antidepressant (25, 26) .
In the third step, linkage of the concepts contained within the outcome measures to the corresponding categories of the ICF, the concepts contained within the outcome measures were extracted and linked to the most specific ICF category by 2 independent health professionals according to a recently developed set of 10 linking rules (21) . If the outcome measure was a laboratory test (e.g. drug blood level of an antidepressant) the goal (compliance) rather than the concept was extracted. Questionnaires not available in English language and those evaluating the effect of an intervention on other units than patients were excluded from linkage, for example the Camberwell Family Interview assessing emotional function in family members of psychiatric patients (27) . Concepts of outcome measures that could not be linked to the ICF were documented and classified in 2 ways: (i) If a concept of an outcome measure was not sufficiently specified to make a decision which ICF category the concept should be linked to, the "not definable" option was chosen (linking rule 9). To give an example, unspecified concepts such as "productivity", "functioning", "enjoying life", "health", or "somatic complaints" were considered not to be definable for linking. (ii) If a concept of an outcome measure was not represented by the ICF, the option "not covered" was chosen (linking rule 10). To give an example, concepts such as "would kill myself if I had a chance" extracted from the Beck Depression Inventory (16) or "wanted to do the opposite of what your relatives wanted …" extracted from the Social Adjustment ScaleSelf Report (28) were considered not to be covered by the ICF.
Consensus between the 2 health professionals was used to decide which ICF category should be linked to each item/concept of the questionnaires. To resolve disagreements between the 2 health professionals concerning the selected categories, a third person trained in the linking rules was consulted. In a discussion led by the third person, the 2 health professionals that linked the item stated their pros and cons for the linking of the concept under consideration to a specific ICF category. Based on these statements, the third person made an informed decision.
To control the plausibility of the linkage procedure the concepts of the outcome measures assigned to the same single ICF category were analysed (e.g. the concepts "feeling inadequate, inferior, worthless, no good" (19) , "feeling disappointed in myself" (16) , "feeling quite guilty" (16) , "feeling miserable/comfortable" (29) , "continuous feeling of inner tension or intermittent panic" (12) , which were linked to the ICF category emotional functions (b152)).
Analyses
Descriptive statistics were used to examine the frequency of ICF categories linked to the concepts contained in the outcome measures. Large-scale cross tables generated from a SQL-database (SQL-Server 2000) were thereby analysed. If the same ICF category was assigned repeatedly in a study, the category was counted only once.
ICF categories are presented on the second level. If a concept of an outcome measure was linked to a third or fourth level ICF category, the overlying second level category was considered. The ICF is organized in a hierarchical scheme, so that the lower-level category shares the attributes of the higher-level category (20) . Only ICF categories with a frequency equal or greater than 10% are shown (preset frequency).
RESULTS
In step 1, 2434 studies were located by the search strategy, 834 studies were preliminarily selected by abstract checking, 406 studies fulfil the eligibility criteria by screening the respective original papers. A computer-generated random sample of 203 studies (50%) was drawn and included into the review.
In step 2, 126 different questionnaires (different versions and subscales of a questionnaire were considered as 1 questionnaire) were extracted. Among them we identified 19 conditionspecific, 102 domain-specific, and 5 generic questionnaires. Domain-specific questionnaire considered dimensions such as anxiety (30) , beliefs and attitudes (31) , coping (32) , functional status (33), life satisfaction (34), mania (35) , personality (36), self-esteem (37), side-effects of psychotropics (38) , or social adjustment (28) . At least 1 health status questionnaire per trial was used in 197 or 97% of the studies. The few remaining trials without health status assessment considered physiological or laboratory outcomes such as physiological sleep parameters, neuroendocrine parameters (39) or heart rate parameters (40) . Type and frequency of the 20 most used questionnaires are shown in Table I . The Hamilton Rating Scale for Depression (15) was applied in 80% of the studies representing the most used health status measure. Domains of single-item measures with a frequency of at least 20% were nausea, dry mouth, headache, dizziness, insomnia, constipation, heart rate, sweating, blood pressure, diarrhoea, weight, somnolence, agitation, compliance (drug blood level), and anxiety, some of them were nearly exclusively assessed in the context of adverse effects evaluation.
In 177 or 87% of studies the study population consisted of patients with MDD, in 6 or 3% of studies the patients had DD and in 1 study the patients had double depression. The remaining study populations consisted of patients with different condition-subtypes such as MDD and DD or MDD and double depression.
Most trials were conducted in the USA (44%), followed by multi-national trials (9%) and trials conducted in France and UK, each with a frequency of 5%. Drug therapy was the most frequently used intervention type with a prevalence of 77% (157 studies), followed by physical or rehabilitative therapy with a prevalence of 16% (32 studies). The remaining 14 trials (7%) dealt with 2 experimental interventions and different intervention types ("different therapeutic modalities"). "Physical or rehabilitative therapy" included psychotherapy (11 studies), light therapy (7 studies), electroconvulsive therapy (7 studies), managed care (6 studies), and acupuncture (1 study). "Managed care" was assigned to "physical or rehabilitative therapy" because this category include complex organized treatment programs (41) (42) (43) (44) as usual applied in rehabilitation medicine.
In step 3, a total of 24 114 concepts were extracted from the outcome measures. Of the 24 114 concepts extracted, a third person was ordered 497 times to resolve differences between the 2 health professionals in their assignment of the ICF categories. 21 561 or 89% of concepts could be linked to the ICF, 1660 or 7% of concepts were considered not to be sufficiently specified for an assignment to the ICF ("not definable option"), and 893 or 4% of concepts were considered to be not covered by the ICF. Of these, 717 concepts describing personal characteristics, 114 referred to "locus of control", 219 to "coping", 20 to "personality", 56 to "life satisfaction", and 308 to "self-esteem". 86% (n = 18 599) of the assignable concepts were linked to the component "body functions", only 12 concepts to the component body structures, 12% (n = 2483) to the component activities and participation, and 2% (n = 460) to the component environmental factors.
The concepts contained in the outcome measures were linked to 454 different ICF categories. Of these there were 250 categories which were linked to the component body functions, 7 to the component "body structures", 173 to component activities and participation and 24 to the component environmental factors.
Five questionnaires were excluded from linking. In 3 cases the questionnaire was not available in English, in 1 case the questionnaire evaluates family members, and in 1 case only the name of the questionnaire was mentioned without a reference given or an item-description in the paper. Table II shows the relative frequency in percentage of ICF categories linked to the concepts contained in the outcome measures as well as differences in the use of ICF categories across different intervention types. The 5 most used ICF categories were sleep functions (b134), emotional functions (b152), energy and drive functions (b130), thought functions (b160) and higher-level cognitive functions (b164). All these categories were highly prevalent reaching frequencies varying between 88% and 94%, all belong to the body functions component, and all represented concepts contained in the 2 most frequently used depression scales of this review, the Hamilton Rating Scale for Depression (15) and the Montgomery-Asberg Depression Rating Scale (12) ( Table I ). The clinical contents underlying these categories were the following: (i) Concepts such as "wake up much earlier than I need" (13), "periods of wakefulness" (45) , "experience of reduced duration or depth of sleep" (12) , or "waking up more tired in the morning" (16) were linked to sleep functions. (ii) Emotional * Different versions or subscales. cs = condition-specific, ds = domain-specific, g = generic.
J Rehabil Med Suppl 44, 2004 functions included concepts such as "feeling no interest in things" (46) , "depressed mood" (12) , "inability to feel" (12), "feeling miserable" (29) , "feeling guilty" (16) , "feeling hopeless" (35) , or "feeling worthless" (19) . (iii) Energy and drive functions included concepts such as "loss of energy" (15) , "difficulty in getting started" (12) , "listless" (47) , "feeling driven to overeat" (48) , or "loss of appetite" (15) . (iv) Thought functions included concepts such as "flight of thoughts" (35) , "slowness of thoughts" (15) , "coherence of thoughts" (35) , or "difficulties in collecting or sustaining thoughts" (12) . (v) Ingestion functions  70  77  31  71  b515  Digestive functions  37  42  9  35  b525  Defecation functions  84  89  53  100  b530  Weight maintenance functions  82  85  59  92  b535  Sensations associated with the digestive system  86  90  59  92  b550  Thermoregulatory functions  11  12  9  b620  Urination functions  50  57  15  50  b640  Sexual functions  82  86  53  92  b650  Menstruation functions  14  17  3  7  b699  Genitourinary and reproductive functions, unspecified  42  43  31  57  b735  Muscle tone functions  15  18  3  7  b765  Involuntary movement functions  34  38  12  21  b780  Sensations related to muscles and movement functions  52  54  37  57  b830  Other functions of the skin  37  44  12  14  d115  Listening  38  43  12  35  d177  Making decisions  82  84  62  92  d230  Carrying out daily routine  38  43  18  21  d335  Producing non-verbal messages  23  17  31  64  d550  Eating  13  15  6  d570  Looking after one's health  62  60  53  92  d599  Self-care, unspecified  16  16  9  28  d640  Doing housework  11  7  18  35  d720  Complex interpersonal interactions  18  12  25  64  d760  Family relationships  10  8  9  35  d770  Intimate relationships  10  10  9  14  d799  Interpersonal interactions and relationships, unspecified  19  12  34  57  d859  Work and employment, other specified and unspecified  81  83  65  92  d920  Recreation and leisure  53  56  28  64  e399  Support and relationships, unspecified  44  50  15  35 AT = all trials; DT = drug therapy; PRT = physical or rehabilitative therapy; DTM = different therapeutic modalities.
J Rehabil Med Suppl 44, 2004 Higher-level cognitive functions included concepts such as "impairment in judgement" (49) , "loss of insight" (15) , "preparation for suicide" (12) , or "solving problems" (33) . The most often used ICF category within the component activities and participation was making decisions (d177), followed by work and employment, other specified and unspecified (d859) with a frequency of 82% and 81%, respectively. The clinical contents underlying "making decisions" included concepts in the meaning of difficulty in making decisions/indecisiveness. Concepts such as "being effective in one's job" (19) , "being ashamed of how you do your work" (28) , "unable to work" (15) , "can work about as well as before" (16), "being able to do your work" (28) were linked to the category work and employment, other specified and unspecified. Other categories with a frequency of at least 50% were looking after one's health (d570) and "recreation and leisure" (d920). Looking after one's health included concepts such as "drug compliance", "adherence to treatment", "following medical advice". Recreation and leisure included concepts such as "participating in sports", "loss of interest in hobbies", "difficulty in relaxing", "socializing", mainly in the sense of visiting friends, relatives or neighbours.
Only 1 category of the environmental factors component reached a frequency of at least 10%. This was the case for support and relationships, unspecified (e399) including concepts such as "requiring urging, guidance, and reassurance" (15) , "needing help with bathing and dressing" (13) or "needing supervision to prevent hurting self or others" (49) .
The ICF categories temperament and personality functions, energy and drive functions, sleep functions, emotional functions, and thought functions were used in more than 75% of all drugtherapy (n = 157), physical-or rehabilitative-therapy studies (n = 32), and studies with different therapeutic modalities (n = 14). All chapters (one-level classification of the ICF) were represented by at least 1 ICF category except for structures of the nervous system (s1), the eye, the ear and related structure (s2) and structures involved in voice and speech (s3).
DISCUSSION
Using the ICF as a reference it was possible to identify and quantify the concepts within the outcome measures used in RCTs for interventions in depressive disorders. Most concepts within the outcome measures could be linked to the ICF and those who could not be linked were mostly not specified in enough detail for an assignment.
Only a very small portion of concepts was considered not covered by the ICF. In these cases the content of the concepts did not lie in the defined universe of the ICF. For example, health status measures on dimensions such as "locus of control" (31), coping (32), "personality" (36) , life satisfaction (34), or selfesteem (37) include personal concepts that are not covered by the current ICF and could therefore not be linked.
The data show, that foremostly concepts about psychological but also on physiological functions were more often represented in outcome measures of trials on depressive disorders compared to concepts dealing with executions of tasks or actions or the participation of an individual in life situations. ICF categories such as self-care (d599), housework (d640), family (d760) or intimate relationships (d770) reached only frequencies just above the pre-set 10% level. Additionally, environmental factors with an impact on functioning in depressive disorders were hardly addressed in outcome measures of trials on depressive disorders. ICF categories such as time-related changes (e245), light (e240), individual attitudes of family member (e410) and friends (e420) or individual attitudes of health professionals (e355) did not even reach the pre-set frequency level. Nearly all ICF categories showed higher frequencies in drug trials than in trials on physical or rehabilitative therapy (nonpharmacological trials). In drug trials different health status measures were used more often simultaneously (data not shown). A reason might be, that drug trials are often sponsored by pharmaceutical companies enabling a greater methodological effort.
Surprisingly, different patterns in the use of ICF categories in drug trials compared with non-pharmacological trials could not be found. The reason might be, that independent of the intervention type nearly all therapeutic options aimed primarily to influence depressive symptomatology.
Our results reflect the "state of art" of concepts used in outcome measures of trials on depressive disorders over the last decade. Secular trends in the use of outcome measures or ICF categories could not be confirmed (data not shown). From a conceptual point of view, the results might be "biased" by a reduced use of functional concepts and environmental factors with an impact on individual life of patients with depressive disorders. More the biological than the social or environmental perspective of the disease was represented in outcome measures of studies on depressive disorders. As a classification system encompassing all aspects of human health, the ICF has the capacity to expand the outcomes commonly measured by psychiatric studies on depressive disorders. It is beyond the scope of this paper to discuss in detail whether the outcome measures used in the studies and therefore the concepts linked to the ICF are appropriate for specific study questions or whether or not they adequately reflect the burden of disease in patients with depressive disorders. However, our findings indicate a need to define "what should be measured" in clinical trials to allow for a more comprehensive and comparable comparison of patient populations across studies and interventions.
Due to limited personal and time resources we had to work with some methodological limitations such as the solely use of MEDLINE 1 , RCTs, studies published in English and outcome measures available in English. Furthermore, we had to draw a random sample of the eligible studies selected. The limitation of the review to RCTs might have introduced an overrepresentation of biological aspects in the outcome assessment of depressive J Rehabil Med Suppl 44, 2004 disorders. Future investigations should review longitudinal observational studies of those with depressive disorders to determine whether they include more outcomes from a social perspective.
In conclusion, the ICF provides a useful reference to identify and quantify the concepts within the outcome measures used in RCTs for interventions on depressive disorders. On the other hand, studies on the outcomes of depressive disorder trials were often limited by the conceptual limitations of their measures.
